tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Tempest Therapeutics reports Q3 EPS (79c) vs ($5.32) last year
PremiumThe FlyTempest Therapeutics reports Q3 EPS (79c) vs ($5.32) last year
18d ago
TPST Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
TPST Earnings this Week: How Will it Perform?
20d ago
Tempest Therapeutics and Adagene’s Promising Advances in Liver Cancer Treatment
Premium
Company Announcements
Tempest Therapeutics and Adagene’s Promising Advances in Liver Cancer Treatment
27d ago
Tempest Therapeutics, Inc. (TPST) Q2 Earnings Cheat Sheet
PremiumPre-EarningsTempest Therapeutics, Inc. (TPST) Q2 Earnings Cheat Sheet
4M ago
Morpheus-Liver Study: A New Horizon in Advanced Liver Cancer Treatment
Premium
Company Announcements
Morpheus-Liver Study: A New Horizon in Advanced Liver Cancer Treatment
4M ago
Tempest Therapeutics’ Promising Advances in Liver Cancer Treatment
Premium
Company Announcements
Tempest Therapeutics’ Promising Advances in Liver Cancer Treatment
5M ago
Tempest Therapeutics receives ODD from EMA for amezalpat
PremiumThe FlyTempest Therapeutics receives ODD from EMA for amezalpat
6M ago
Tempest Therapeutics Reports Q1 2025 Financial Results
Premium
Company Announcements
Tempest Therapeutics Reports Q1 2025 Financial Results
6M ago
Tempest Therapeutics: Navigating Financial Challenges with Promising Clinical Data and Strategic Partnerships
Premium
Ratings
Tempest Therapeutics: Navigating Financial Challenges with Promising Clinical Data and Strategic Partnerships
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100